Enabling the large-scale analysis of quantitative high-throughput screening data

Handbook of Drug Screening: Second Edition

Volumn , Issue , 2016, Pages 442-464

  Southall, Noel T ^a   Jadhav, Ajit ^a   Huang, Ruili ^a   Nguyen, Trung ^a   Wang, Yuhong ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85051691015     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (36)

1. Cox B, Denyer JC, Binnie A, et al. Application of high-throughput screening techniques to drug discovery. Prog Med Chem 2000; 37: 83-133.
2. Spencer RW. High-throughput screening of historic collections: Observations on file size, biological targets, and file diversity. Biotechnol Bioeng 1998; 61(1): 61-67.
3. Schneider G, Clement-Chomienne O, Hilfiger L, et al. Virtual screening for bioactive molecules by evolutionary De Novo design. Angew Chem Int Ed Engl 2000; 39(22): 4130-4133.
4. Marriott DP, Dougall IG, Meghani P, et al. Lead generation using pharmacophore mapping and three-dimensional database searching: Application to muscarinic M(3) receptor antagonists. J Med Chem 1999; 42(17): 3210-3216.
5. Milne GW, Nicklaus MC, Wang S. Pharmacophores in drug design and discovery. SAR QSAR Environ Res 1998; 9(1-2): 23-38.
6. Gane PJ, Dean PM. Recent advances in structure-based rational drug design. Curr Opin Struct Biol 2000; 10(4): 401-404.
7. Huang N, Jacobson MP. Physics-based methods for studying protein-ligand interactions. Curr Opin Drug Discov Dev 2007; 10(3): 325-331.
8. Coupez B, Lewis, RA. Docking and scoring-theoretically easy, practically impossible? Curr Med Chem 2006; 13(25): 2995-3003.
9. Hillenmeyer ME, Fung E,Wildenhain J, et al. The chemical genomic portrait of yeast: Uncovering a phenotype for all genes. Science 2008; 320(5874): 362-365.
10. Inglese J, Auld DS, Jadhav A, et al. Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci U S A 2006; 103(31): 11473-11478.
11. Kozarich JW. New LSD therapies unfolding. Chem Biol 2007; 14(9): 976-977.
12. Davis RE, Zhang Y-Q, Southall N, et al. A cellular assay for IκBα stabilization using a two-color dual luciferase-based sensor. Assay Drug Dev Technol 2007; 5: 85-103.
13. Simeonov A, Jadhav A, Thomas CJ, et al. Fluorescence spectroscopic profiling of compound libraries. J Med Chem 2008; 51(8): 2363-2371.
14. Xia M, Huang R, Witt KL, et al. Compound cytotoxicity profiling using quantitative high-throughput screening. Environ Health Perspect 2008, 116(3): 284-291.
15. Huang R, Southall N, Cho MH, et al. Characterization of diversity in toxicity mechanism using in vitro cytotoxicity assays in quantitative high throughput screening. Chem Res Toxicol 2008; 21(3): 659-667.
16. PubChem, IkB Signaling qHTS Assay. http://pubchem.ncbi.nlm.nih.gov/assay /assay.cgi?aid=445.
17. Yasgar A, Shinn P, Jadhav A, et al. Compound management for quantitative highthroughput screening. JALA 2008; 13(2): 79-89.
18. NCGC, Eli Lilly and Company. Assay Guidance Manual. http://www.ncgc.nih.gov /guidance/index.html.
19. Malo N, Hanley JA, Cerquozzi S, et al. Statistical practice in high-throughput screening data analysis. Nat Biotechnol 2006; 24(2): 167-175.
20. Heyse S, Brodte A, Bruttger O, et al. Quantifying bioactivity on a large scale: quality assurance and analysis of multiparametric ultra-HTS data. JALA 2005; 10(4): 207-212.
21. Lundholt BK, Scudder KM, Pagliaro L. A simple technique for reducing edge effect in cell-based assays. J Biomol Screen 2003; 8(5): 566-570.
22. Britanak V, Yip P, Rao KR. Discrete Cosine and Sine Transforms. Academic Press, 2006.
23. Motulsky H, Christopoulos A. Fitting models to biological data using linear and nonlinear regression: A practical guide to curve fitting. New York: Oxford University Press, 2004.
24. Goode DR, Totten RK, Heeres, JT, et al. Identification of promiscuous small molecule activators in high-throughput enzyme activation screens. JMed Chem 2008; 51(8): 2346-2349.
25. Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol 1910; 40(Suppl): iv-vii.
26. Weiss JN. The Hill equation revisited: uses and misuses. FASEB J 1997; 11(11): 835-841.
27. Huang DM, Chandler D. Cavity formation and the drying transition in the lennardjones fluid. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 2000; 61(2): 1501-1506.
28. Invitrogen, GeneBLAzer® Technology Overview. http://www.invitrogen.com /site/us/en/home/Products-and-Services/Applications/Drug-Discovery/Targetand-Lead-Identification-and-Validation/g-protein coupled html/GPCR-Cell-Based-Assays/GeneBLAzer-Theory.html.
29. Yan SF, Asatryan H, Li J, et al. Novel statistical approach for primary high-throughput screening hit selection. J Chem Inf Model 2005; 45(6): 1784-1790.
30. Leadscope Leadscope, Columbus, OH: Leadscope.
31. PubChem, qHTS Assay for Inhibitors of HADH2. http://pubchem.ncbi.nlm.nih.gov /assay/assay.cgi?aid=886.
32. Shafqat N, Marschall HU, Filling C, et al. Expanded substrate screenings of human and Drosophila type 10 17beta-hydroxysteroid dehydrogenases (HSDs) reveal multiple specificities in bile acid and steroid hormone metabolism: Characterization ofmultifunctional 3alpha/7alpha/7beta/17beta/20beta/21-HSD. Biochem J 2003; 376(Pt 1): 49-60.
33. PubChem, Cell signaling CRE-BLA (Fsk stim). http://pubchem.ncbi.nlm.nih.gov/ assay/assay.cgi?aid=662.
34. PubChem, Pyruvate Kinase. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?.
35. PubChem, qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=926.
36. GeneData GeneData Screener, GeneData AG, Basel, Switzerland.